(Q42349769)

27 October 2017

In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy (English)

1 reference

27 October 2017

Davis TM

1

1 reference

27 October 2017

Bown E

2

1 reference

27 October 2017

Finch DR

3

1 reference

27 October 2017

Mitchell MD

4

1 reference

27 October 2017

Turner RC

5

1 reference

27 October 2017

language of work or name

English

0 references

publication date

1 April 1981

1 reference

27 October 2017

4

1 reference

inferred from page(s)

published in

The BMJ

1 reference

27 October 2017

282

1 reference

27 October 2017

1259-1262

1 reference

27 October 2017

6272

1 reference

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

27 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

En face organ culture of vascular endothelium

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Age-dependent increase in the formation of prostaglandin I2 by intact and homogenised aortae from the developing spontaneously hypertensive rat

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Decreased vascular prostacyclin in experimental diabetes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

A sensitive radioimmunoassay for 6-keto-prostaglandin F1α: preliminary observations on circulating concentrations

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Hyperglycaemia and diabetes mellitus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1505380

Treatment of diabetes and retinal complications

29 May 2018

1 reference

12 December 2020

Decreased vascular prostacyclin in juvenile-onset diabetes

1 reference

12 December 2020

Vascular prostacyclin may be reduced in diabetes in man

1 reference

12 December 2020

Stability of prostacyclin in plasma

1 reference

12 December 2020

Prostacyclin and thromboxane metabolites in diabetes

1 reference

12 December 2020

Circulating prostacyclin may be reduced in diabetes

1 reference

12 December 2020

Is prostacyclin a physiologically important circulating anti-platelet agent?

1 reference

12 December 2020

Plasma 6-keto-PGF1 alpha concentrations and diabetic retinopathy

1 reference

12 December 2020

Effect of insulin treatment on prostacyclin in experimental diabetes

1 reference

12 December 2020

Increased prostacyclin release from perfused hearts of acutely diabetic rats

1 reference

12 December 2020

10.1136/BMJ.282.6272.1259

Identifiers

DOI

0 references

1 reference

27 October 2017

1 reference